Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hepatitis
Phenotype C0022658|renal disease
Sentences 15
PubMedID- 20356392 Clinical trials evaluating the efficacy and safety of gm-csf as an adjuvant to hepatitis b vaccine in patients with end-stage renal disease showed improved seroprotection rates with hbv vaccine after gm-csf administration [27].
PubMedID- 20150020 Objective: to assess the histologic prevalence of immune-mediated thyroid, pituitary, and adrenal diseases in postmortem cases with hepatitis c.
PubMedID- 25644891 Detection of hepatitis c virus in patients with terminal renal disease undergoing dialysis in southern brazil: prevalence, risk factors, genotypes, and viral load dynamics in hemodialysis patients.
PubMedID- 22310778 Cryoglobulinemic membranoproliferative glomerulonephritis (mpgn) is the more characteristic renal disease associated with hepatitis c virus (hcv) infection.
PubMedID- 21699813 Full-dose peginterferon alfa-2a and low-dose ribavirin treatment of genotypes 1 and 4 chronic hepatitis c patients with end-stage renal disease.
PubMedID- 22964112 Optimization and application of subtype specific polymerase chain reaction for detection and identification of mixed subtypes of hepatitis c virus in patients with renal disease.
PubMedID- 23716924 renal disease associated with hepatitis c virus (hcv) infection includes membranoproliferative glomerulonephritis commonly with or without cryoglobulinemia, and membranous glomerulopathy.
PubMedID- 22310582 Clinical outcome of renal transplantation in end-stage renal disease patients with positive pretransplantation hepatitis b surface antigen.
PubMedID- 24983308 Kidney transplantation alone in end-stage renal disease patients with hepatitis b liver cirrhosis: a single-center experience.
PubMedID- 23425817 Eligible studies were cohort studies that analyzed adult end-stage renal disease patients with hepatitis c virus infection and compared death rates between waiting list and kidney transplantation.
PubMedID- 21273235 Different kinetics of hbv and hcv during haemodialysis and absence of seronegative viral hepatitis in patients with end-stage renal disease.
PubMedID- 26095179 Safety, efficacy and tolerability of half-dose sofosbuvir plus simeprevir in treatment of hepatitis c in patients with end stage renal disease.
PubMedID- 21814382 This 38-year-old gentleman, known case of end-stage renal disease (esrd) with acute hepatitis e in resolving phase, presented to our emergency opd with complaints of multiple episodes of malena for 1 day.
PubMedID- 25894147 In this study, we aimed to identify the severity of liver disease in endstage renal disease patients with chronic hepatitis c virus infection, the progression of hepatic histopathology after kidney transplant, and whether immunosuppressive therapy affected posttransplant viral replication and hepatic histology.
PubMedID- 20056985 Objective: end-stage renal disease (esrd) patients with hepatitis c virus (hcv) infection are associated with an increasing mortality risk on hemodialysis (hd) and peritoneal dialysis (pd).

Page: 1